VitaNova Life Sciences (VNOV) EBT (2017 - 2026)
VitaNova Life Sciences (VNOV) reported EBT of $46731.0 for Q1 2026, down 56.83% on a YoY basis from $108257.0 in Q1 2025, and down 52.93% quarter-over-quarter from $99290.0 in Q4 2025.
VitaNova Life Sciences (VNOV) EBT (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has reported EBT for 10 years, with the latest figure at $46731.0 in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 56.83% year-over-year to $46731.0; the trailing twelve-month figure through Jan 2026 stood at $1.2 million (up 235.09% YoY), and the FY2025 full-year result was $1.2 million, up 485.37% from the prior year.
- EBT for Q1 2026 stood at $46731.0, down from $99290.0 in the prior quarter.
- The five-year high for EBT was $1.1 million in Q2 2025, with the low at -$45414.0 in Q3 2024.
- Historically, EBT has averaged $87147.2 across 5 years, with a median of $2601.0 in 2022.
- Annual changes were most pronounced in 2023 — EBT slumped 1236.22% — and 2024, when it soared 5408.73%.
- VitaNova Life Sciences' EBT stood at $2601.0 in 2022, then plunged by 436.6% to -$8755.0 in 2023, then jumped by 794.17% to $60775.0 in 2024, then soared by 63.37% to $99290.0 in 2025, then plunged by 52.93% to $46731.0 in 2026.
- The last three EBT figures came in at $46731.0 (Q1 2026), $99290.0 (Q4 2025), and -$32440.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.13 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 2.09 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 392.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 150.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -16.25 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -8.94 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -928,000.00 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -2.81 Mn |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | 46,731.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 46,731.00 |
| Oct 31, 2025 | 99,290.00 |
| Jul 31, 2025 | -32,440.00 |
| Apr 30, 2025 | 1.08 Mn |
| Jan 31, 2025 | 108,257.00 |
| Oct 31, 2024 | 60,775.00 |
| Jul 31, 2024 | -45,414.00 |
| Apr 30, 2024 | 232,788.00 |
| Jan 31, 2024 | 5,948.00 |
| Oct 31, 2023 | -8,755.00 |
| Jul 31, 2023 | -24,247.00 |
| Apr 30, 2023 | -4,385.00 |
| Jan 31, 2023 | -24,577.00 |
| Oct 31, 2022 | 2,601.00 |
| Jul 31, 2022 | 2,134.00 |
| Apr 30, 2022 | -26,807.00 |
| Jan 31, 2022 | 8,917.00 |
| Oct 31, 2021 | 15,009.00 |
| Jul 31, 2021 | 142,563.00 |
| Apr 30, 2021 | -25,563.00 |